StonvexLoading…
StonvexStonvexStonvexCore line items from AKTS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Q1 2025 2025-03-31 |
|---|---|---|
Revenue | $3.23M | $1.45M |
Operating Income | $-22.71M | $-18.14M |
Net Income | $-18.32M | $-14.98M |
EPS (Diluted) | $-0.38 | $-18.60 |
Total Assets | $576.80M | Not available |
Total Liabilities | $70.69M | Not available |
Cash & Equivalents | $371.63M | $58.25M |
Free Cash Flow OCF − CapEx | $-26.10M | $-19.38M |
Shares Outstanding | 53.40M | 805.82K |